Hospital stocks like Apollo Hospitals and Fortis Healthcare fell for a second straight session on Thursday. The Supreme Court questioned steep markups on cancer drugs, causing market worry. Despite this, Jefferies said, "Jefferies sees this as an excellent entry point to buy these 6 stocks" for long-term growth and gains.
Hospital stocks including Fortis Healthcare, Dr Agarwal’s, Manipal, Apollo Hospitals and Medanta extended their losses for a second straight session on Thursday, after falling as much as 10% in the previous session, as the Supreme Court questioned steep markups on cancer drugs and asked the government to examine allegations that hospitals require patients to purchase medicines from their own or designated pharmacies. However, Jefferies sees this as an excellent entry point to buy these 6 stocks.
Jefferies has a Buy rating on Medanta with a target price of Rs 1,660, implying 22% upside, while its FY26E-29E EBITDA CAGR is estimated at 22%.